<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Label-free technologies for drug discovery</title>
  </titleInfo>
  <name type="personal">
    <namePart>Cooper, M. A. (Matthew A.)</namePart>
  </name>
  <name type="personal">
    <namePart>Mayr, Lorenz.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">enk</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Chichester, West Sussex, U.K</placeTerm>
    </place>
    <publisher>John Wiley &amp; Sons</publisher>
    <dateIssued>2011</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource</extent>
  </physicalDescription>
  <abstract>Over the past two decades the benefits of label-free biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as mainstream research tools in many drug discovery laboratories. Label-Free Technologies For Drug Discovery summarises the latest and emerging developments in label-free detection systems, their underlying technology principles and end-user case studies that reveal the power and limitations of label-free in all areas of drug discovery. Label-free technologies discussed include SPR, NMR, high-throughput mass spectrometry, resonant waveguide plat.</abstract>
  <tableOfContents>Front Matter -- The Revolution of Real-Time, Label-Free Biosensor Applications / Rebecca L Rich, David G Myszka -- Design and Implementation of Vertically Emitting Distributed Feedback Lasers for Biological Sensing / Meng Lu, Steven S Choi, Chun Ge, Clark J Wagner, J Gary Eden, Brian T Cunningham -- SPR Screening of Chemical Microarrays for Fragment-Based Discovery / Thomas Neumann, Renate Sekul -- The CellKeyʼ System: A Label-Free Cell-Based Assay Platform for Early Drug Discovery Applications / Ryan P McGuinness, Debra L Gallant, Yen-Wen Chen, Trisha A Tutana, Donna L Wilson, John M Proctor, H Roger Tang -- Dynamic and Label-Free Cell-Based Assays Using the xCELLigence System / Yama A Abassi, Alexander Sieler, Manfred Watzele, Xiaobo Wang, Xiao Xu -- Selecting the Best HTS Hits to Move Forward: ITC Ligand Binding Characterization Provides Guidance / Ronan O'Brien, Richard Brown -- Incorporating Transmitted Light Modalities into High-Content Analysis Assays / Robert Graves -- Nonradioactive Rubidium Efflux Assay Technology for Screening of Ion Channels / Georg C Terstappen -- Expanding the Scope of HTMS Methods / Tom G Holt, Jun Wang, Xun Chen, Bernard K Choi, Neil S Geoghagen, Kristian K Jensen, Maxine Jonas, Qi Luo, William A LaMarr, Lorraine Malkowitz, Can C Ozbal, Yusheng Xiong, Claude Dufresne, Ming-Juan Luo -- A Novel Multiplex SPR Array for Rapid Screening and Affinity Determination of Monoclonal Antibodies: The ProteOn XPR36 Label Free System: Kinetic Screening of Monoclonal Antibodies / Vered Bronner, Oded Nahshol, Tsafrir Bravman -- Biophysics/Label-Free Assays in Hit Discovery and Verification / Johannes Ottl -- Harnessing Optical Label-Free on Microtiter Plates for Lead Finding: From Binding to Phenotypes / Julio Martin -- Use of Label-Free Detection Technologies in the Hit-to-Lead Process: Surface Optical Detection of Cellular Processes / F Stuhmeier, J Bradley, E Fairman, E Gbekor, P Hayter, S Ramsey -- Cellular Screening for 7TM Receptors Using Label-Free Detection / Jeffrey C Jerman, Jason Brown, Magalie Rocheville -- Novartis Evaluation of the ForteBio Octet RED: A Versatile Instrument for Direct Binding Experiments / Eric Martin, John Wang, Isabel Zaror, Jiamin Yu, Kelly Yan, Mike Doyle, Paul Feucht, Kevin Shoemaker, Bob Warne, Mike Chin, Blisseth Sy, Lukas Leder, Marco Meyerhofer, Charles Wartchow, Danfeng Yao -- The Pyramid₉ Approach to Fragment-Based Biophysical Screening / Glyn Williams -- Characterisation of Antibodies Against the Active Conformation of G Using the SRU-BINDʼ Label-Free Detection System / Melanie Leveridge, Chun-Wa Chung, Trevor Wattam -- SPR-Based Direct Binding Assays in Drug Discovery / Walter Huber -- Kinetic Binding Mechanisms: Their Contribution to an Optimal Therapeutic Index / David C Swinney -- ITC: More Than Just Binding Affinities / Ernesto Freire -- Index.</tableOfContents>
  <tableOfContents>The revolution of real-time, label-free biosensor applications / Rebecca L. Rich and David G. Myszka -- Design and implementation of vertically emitting distributed feedback lasers for biological sensing / Meng Lu [and others] -- SPR screening of chemical microarrays for fragment based discovery / Thomas Neumann and Renate Sekul -- The cellkey system : a label-free cell-based assay platform for early drug discovery applications / Ryan P. McGuinness [and others] -- Dynamic and label-free cell-based assays using the xcelligence system / Yama A. Abassi [and others] -- Selecting the best HTS hits to move forward : ITC ligand binding characterization provides guidance / Ronan O'Brien &amp; Richard Brown -- Incorporating transmitted light modalities into high-content analysis assays / Robert Graves -- Nonradioactive rubidium efflux assay technology for screening of ion channels / Georg C. Terstappen -- Expanding the scope of HTMS methods / Tom G. Holt [and others] -- A novel multiplex SPR array for rapid screening and affinity determination of monoclonal antibodies : the proteon XPR36 label free system : kinetic screening of monoclonal antibodies / Vered Bronner, Oded Nahshol, and Tsafrir Bravman -- Biophysics/label-free assays in hit discovery and verification / Johannes Ottl -- Harnessing optical label-free on microtiter plates for lead finding from binding to phenotypes / Julio Martin -- Use of label-free detection technologies in the hit-to-lead process: surface optical detection of cellular processes / F. Stuhmeier [and others] -- Cellular screening for 7TMS using label-free detection / Jeffrey C. Jerman, Jason Brown, and Magalie Rocheville -- Novartis evaluation of the ForteBio Octet RED : a versatile instrument for direct-binding experiments / Eric Martin [and others] -- The pyramid approach to fragment-based biophysical screening / Glyn Williams -- Characterisation of antibodies against the active conformation of Gài1 using the SRU-BIND label free detection system / Melanie Leveridge, Chun-Wa Chung, and Trevor Wattam -- SPR based direct binding assays in drug discovery / Walter Huber -- Kinetic binding mechanisms: their contribution to an optimal therapeutic index / David C. Swinney -- ITC : more than just binding affinities / Ernesto Freire.</tableOfContents>
  <note type="statement of responsibility">editors, Matthew Cooper, Lorenz Mayr.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <subject authority="mesh">
    <topic>Drug Discovery</topic>
  </subject>
  <subject authority="mesh">
    <topic>Biosensing Techniques</topic>
  </subject>
  <subject authority="mesh">
    <topic>Drug Design</topic>
  </subject>
  <subject>
    <topic>Medicine</topic>
  </subject>
  <subject>
    <topic>Pharmacy</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Drug Guides</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Nursing</topic>
    <topic>Pharmacology</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Pharmacology</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Pharmacy</topic>
  </subject>
  <subject authority="fast">
    <topic>Drug development</topic>
  </subject>
  <classification authority="lcc">RM301.25 .L33 2011</classification>
  <classification authority="ddc" edition="22">615/.19</classification>
  <classification authority="nlm">QV 744</classification>
  <relatedItem type="otherFormat" displayLabel="Print version:">
    <titleInfo>
      <title>Label-free technologies for drug discovery</title>
    </titleInfo>
    <originInfo>
      <publisher>Chichester, West Sussex, U.K. : John Wiley &amp; Sons, 2011</publisher>
    </originInfo>
    <identifier type="local">(DLC)  2010042191</identifier>
    <identifier type="local">(OCoLC)669122339</identifier>
  </relatedItem>
  <identifier type="isbn">9780470979129</identifier>
  <identifier type="isbn">0470979127</identifier>
  <identifier type="isbn">9780470979136</identifier>
  <identifier type="isbn">0470979135</identifier>
  <identifier type="isbn">9780470746837</identifier>
  <identifier type="isbn">0470746831</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="stock number">10.1002/9780470979129 Wiley InterScience</identifier>
  <identifier type="uri">http://onlinelibrary.wiley.com/book/10.1002/9780470979129</identifier>
  <location>
    <url>http://onlinelibrary.wiley.com/book/10.1002/9780470979129</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">DG1</recordContentSource>
    <recordCreationDate encoding="marc">110304</recordCreationDate>
    <recordChangeDate encoding="iso8601">20171119105809.0</recordChangeDate>
    <recordIdentifier source="OCoLC">ocn705353428</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
